Essity AB stock (SE0009922164): hygiene and health group in focus after latest quarterly results

Essity AB has recently reported new quarterly figures and continues to refine its hygiene and health portfolio. What the latest numbers reveal about growth, margins and regional trends – and why the stock also matters for US-based investors.

Essity AB, the Swedish hygiene and health company behind brands such as TENA and Tork, recently presented new quarterly figures that shed light on its current growth path and profitability trends, according to a results release published in late April 2026 on the company’s website and summarized by financial portals such as Reuters and regional Nordic business media. The update follows strong price and mix effects in 2025 and continuing optimization efforts in 2026, according to Essity investor information as of 04/26/2026 and coverage from Reuters as of 04/26/2026.

As of: 15.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Essity AB
• Sector/industry: Hygiene and health products
• Headquarters/country: Stockholm, Sweden
• Core markets: Europe, North America, Latin America, Asia
• Key revenue drivers: Tissue, incontinence products, professional hygiene solutions
• Home exchange/listing venue: Nasdaq Stockholm (ticker: ESSITY B)
• Trading currency: Swedish krona (SEK)

Essity AB: core business model

Essity AB describes itself as a global hygiene and health company with a focus on essential everyday products, including personal care items, tissue and professional hygiene solutions, according to company information on its website and investor presentations. The group’s brand portfolio includes well-known names such as TENA for incontinence care and Tork for professional hygiene, alongside several tissue and baby care brands in Europe and other regions, as outlined on Essity company information as of 03/2026.

The business model combines manufacturing, marketing and distribution of branded consumer products with tailored solutions for professional clients such as hospitals, nursing homes, offices, food service and industrial customers. Essity emphasizes its innovation work in absorbent hygiene products and fiber-based tissue, as well as increasingly digital service concepts for professional hygiene, according to recent strategy and sustainability materials published by the company in 2025 and 2026 on its investor pages.

A significant part of Essity’s strategy revolves around scale and efficiency in its production network, supported by long-term supplier relationships for pulp, polymers and packaging materials. The company has highlighted cost and capital efficiency programs over recent years, designed to improve margins and free up funds for targeted investments and bolt-on acquisitions, as referenced in Essity’s annual and quarterly reporting materials released in 2024 and 2025 on its investor relations site.

Main revenue and product drivers for Essity AB

Essity structures its activities across several business areas, typically including Health & Medical, Consumer Goods and Professional Hygiene, with each area contributing differently to sales and profit, according to descriptions provided in recent Essity annual reports and presentations published in 2025 on the corporate website. Health & Medical focuses on incontinence products, wound care and compression therapy, while Consumer Goods covers toilet tissue, kitchen rolls, facial tissues and feminine care products sold through retail channels.

The Professional Hygiene business is centered on the Tork brand, offering paper towels, toilet tissue, napkins, soaps, dispensers and related services for workplaces, hotels, restaurants, healthcare institutions and public venues. Essity has emphasized that this unit benefits from recurring demand linked to hygiene standards and regulations, and that increased awareness of hygiene after the pandemic has structurally supported long-term volumes, according to Essity’s strategy updates and capital markets material published in 2024 and 2025.

Geographically, sales are diversified across Europe, North America, Latin America and Asia, with Europe historically representing a significant share of revenue. The company has repeatedly highlighted growth opportunities in emerging markets, where rising incomes and urbanization boost demand for branded hygiene products, as mentioned in Essity’s market overview sections in its 2024 annual report and 2025 investor presentations. Currency movements and raw material prices are important external drivers, influencing both reported sales and margins.

Latest quarterly figures and profitability trends

In its most recent quarterly report, Essity AB reported continued growth in sales and an improvement in profitability compared with the prior-year period, driven by price effects, a more favorable product mix and ongoing efficiency measures, according to Essity’s quarterly earnings release published in late April 2026 on the investor relations site. The company pointed to robust performance in Health & Medical and Professional Hygiene, while some consumer tissue categories continued to normalize after sharp price increases in previous years.

Management highlighted the impact of previously implemented cost programs, including streamlined production, supply chain optimization and SG&A savings, which together supported an expansion of the operating margin year over year. At the same time, Essity noted that raw material costs have stabilized compared with the spikes seen in 2022 and early 2023, though the company continues to monitor pulp and energy prices closely, according to the April 2026 quarterly report and the accompanying presentation on Essity’s investor site.

Cash flow generation remained an area of attention, with Essity indicating that working capital development and capital expenditure were in line with internal plans for the quarter. The group reiterated its priorities of maintaining a solid balance sheet, continuing to invest in growth projects and returning capital to shareholders through an ordinary dividend, as outlined in the quarterly communication and recent AGM documentation made available on the company’s investor relations pages in spring 2026.

Dividend policy and capital allocation

Essity AB has a track record of paying regular dividends and has communicated a policy aimed at a stable, gradually rising payout aligned with underlying earnings and cash flow development, according to dividend information in Essity’s 2024 annual report and AGM materials published in early 2025 on the investor site. The annual general meeting in 2025 approved a dividend distribution reflecting the company’s earnings level and financial position at that time, as documented in Essity’s AGM minutes and notices.

Beyond dividends, Essity’s capital allocation framework includes investments in capacity, efficiency improvements and innovation, as well as selective acquisitions intended to strengthen positions in priority segments and geographies. The company has completed various portfolio measures in recent years, including divestments of non-core or lower-return assets and acquisitions in higher-growth categories such as medical solutions and professional hygiene, according to transaction overviews contained in Essity’s 2024 and 2025 reporting.

Management has emphasized that maintaining an investment-grade credit profile and a balanced leverage ratio remains a key objective. This provides flexibility to manage cyclical swings in raw material costs and currency while still funding long-term strategic initiatives. The approach, as described in Essity’s financial policy and capital markets day materials, is designed to support both resilience and disciplined growth.

Strategic initiatives and sustainability focus

Strategically, Essity continues to focus on strengthening its leading positions in core product categories, innovating in health and hygiene solutions, and improving cost efficiency. The company regularly updates investors on progress in product innovation, such as more sustainable tissue products with higher recycled or alternative fiber content, redesigned packaging with lower plastic use, and new digital service offerings under the Tork brand for facility management, as discussed in Essity’s sustainability and strategy reports for 2024 and 2025.

Sustainability is deeply integrated into Essity’s strategy, with targets on reducing greenhouse gas emissions, increasing the share of renewable and recycled materials, and promoting circular solutions for hygiene products. The company reports on its progress towards climate and resource efficiency goals in its annual sustainability report, which is released alongside or shortly after the annual report, according to Essity’s ESG disclosures published in 2025 and 2026 on the corporate website.

In the medical and health segment, Essity aims to broaden its offering in areas such as incontinence care, wound care and compression therapy, including solutions that support home-based care and digital patient support, based on product and market descriptions in Essity’s health and medical portfolio documents. This aligns with broader healthcare trends toward cost efficiency, aging populations and increased attention to quality of life, which the company sees as structural growth drivers for its offerings.

Industry trends and competitive position

The global hygiene and health market is shaped by demographic trends, higher hygiene standards and growing healthcare needs. Incontinence products and wound care are influenced by aging populations and greater recognition of chronic conditions, with Essity competing against other international players in these niches. Industry analyses and market research published between 2024 and 2026 by sector-focused firms highlight ongoing growth in advanced wound care and incontinence segments as key drivers of the broader medical consumables market.

In tissue and professional hygiene, competition remains intense, with global, regional and private-label manufacturers vying for shelf space and contracts. Essity’s brands, scale and distribution network are central to its competitive positioning, as noted in the competitive landscape sections of its 2024 annual report and 2025 capital markets presentations. The company aims to differentiate through product performance, sustainability credentials and value-added services, particularly in the professional hygiene segment.

At the same time, retailers’ bargaining power in consumer tissue and the continued expansion of private-label products in some markets can weigh on pricing and margins. Essity has responded with brand building, product innovation and efficiency measures to protect profitability. For investors, understanding how these industry dynamics interact with Essity’s cost and pricing actions is essential when interpreting quarterly fluctuations in sales and margins.

Why Essity AB matters for US investors

Although Essity’s primary listing is on Nasdaq Stockholm, the company also trades in the United States over-the-counter under the symbol ETTYF, giving US-based investors access to its shares via the OTC market, according to trading information on US market data platforms as of early 2026. This OTC presence, combined with the company’s sales exposure to North America, makes Essity relevant for US investors seeking diversified international healthcare and consumer staples exposure.

Essity generates a meaningful portion of its revenue in North America through its Tork professional hygiene business and various health and medical solutions, according to regional breakdowns in Essity’s 2024 and 2025 reporting. Demand in these segments is linked to economic activity, healthcare utilization and institutional hygiene standards in the US and Canada, meaning that developments in the US economy can directly influence parts of Essity’s performance.

From a portfolio perspective, the company sits at the intersection of healthcare and consumer staples, two sectors often considered for diversification and defensive characteristics in global equity allocations. For US investors who focus heavily on domestic large caps, Essity represents a way to gain exposure to hygiene and medical consumables with a European base but global reach, including operations in North America, Latin America and Asia.

Conclusion

Essity AB’s latest quarterly figures underline its role as a globally active hygiene and health provider with diversified revenue streams and a continued focus on efficiency and margin improvement. The combination of branded consumer products, professional hygiene solutions and health and medical offerings positions the company in structurally growing end markets, while also exposing it to cyclical factors such as raw material costs and economic activity in key regions. For US-based investors, Essity offers international exposure to healthcare-related consumables and hygiene products via an OTC listing, complemented by a dividend profile and clearly communicated capital allocation priorities. As always, individual investment decisions depend on each investor’s risk tolerance, time horizon and overall portfolio objectives.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.